المؤلفون: John V. Heymach, Philip C. Mack, Karen Kelly, Mario R. Velasco, Fred R. Hirsch, Mary W. Redman, Edward S. Kim, Roy S. Herbst, James J. Moon, Shaker R. Dakhil, David R. Gandara

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol 8, iss 12
Kim, ES; Moon, J; Herbst, RS; Redman, MW; Dakhil, SR; Velasco, MR; et al.(2013). Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer SWOG S0536. Journal of Thoracic Oncology, 8(12), 1519-1528. doi: 10.1097/JTO.0000000000000009. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/5v47h38xTest

مصطلحات موضوعية: Oncology, Male, Lung Neoplasms, Cetuximab, Cardiorespiratory Medicine and Haematology, Carboplatin, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Monoclonal, Clinical endpoint, Non-Small-Cell Lung, Humanized, 0303 health sciences, Middle Aged, Prognosis, 3. Good health, Survival Rate, Bevacizumab, Tolerability, 030220 oncology & carcinogenesis, Female, medicine.drug, Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Paclitaxel, Clinical Sciences, Oncology and Carcinogenesis, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Article, Antibodies, 03 medical and health sciences, Internal medicine, medicine, Humans, Frontline, Oncology & Carcinogenesis, Lung cancer, Survival rate, 030304 developmental biology, Neoplasm Staging, Aged, business.industry, Non–small-cell lung cancer, Carcinoma, medicine.disease, Regimen, chemistry, Feasibility Studies, business, Non-small-cell lung cancer, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22cb9fee1674df9b93161b24076efabTest
https://escholarship.org/uc/item/5v47h38xTest

المؤلفون: Craig Howe, Ju Whei Lee, Mario R. Velasco, Joan H. Schiller, Chandra P. Belani, Jill M. Kolesar, Suresh S. Ramalingam, Seena C. Aisner

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(13)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Green Fluorescent Proteins, Phases of clinical research, Cetuximab, Antineoplastic Agents, medicine.disease_cause, Antibodies, Monoclonal, Humanized, Internal medicine, Original Reports, medicine, Carcinoma, Humans, Lung cancer, EGFR inhibitors, Aged, Aged, 80 and over, Performance status, business.industry, Antibodies, Monoclonal, Adenocarcinoma, Bronchiolo-Alveolar, Middle Aged, medicine.disease, Adenocarcinoma, Female, KRAS, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e90d93aca6d6b6e5c59b79a75f7b57Test
https://pubmed.ncbi.nlm.nih.gov/21422434Test